{"id":"W2044991833","doi":"10.1177/0091270007307572","title":"Pharmacokinetics of Lamivudine, Zidovudine, and Nevirapine Administered as a Fixed‐Dose Combination Formulation Versus Coadministration of the Individual Products","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Nuvo Pharmaceuticals (Canada); Patheon (Canada); BioPhage Pharma (Canada); Quebec Rehabilitation Research Network","funders":"","keywords":"Nevirapine; Fixed-dose combination; Lamivudine; Zidovudine; Pharmacokinetics; Bioequivalence; Pharmacology; Medicine; Crossover study; Viral load; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Viral disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007844174,0.000474957,0.001404295,0.0003239945,0.0001634981,0.0004641675,0.0004703698,0.0005381167,0.001166984],"category_scores_gemma":[0.001852289,0.0005751991,0.0005048296,0.0003808006,0.0004800382,0.0004315891,0.0001373595,0.0009279404,0.0002105014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004350624,"about_ca_system_score_gemma":0.0004181291,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001086769,"about_ca_topic_score_gemma":0.001486368,"domain_scores_codex":[0.9990345,0.0004123043,0.00004946097,0.0002024705,0.0002250678,0.00007620851],"domain_scores_gemma":[0.9993039,0.0001980881,0.0002173874,0.00006810943,0.00004657416,0.000165912],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4567382,0.01814964,0.01281691,0.0003414715,0.001588391,0.0002058878,0.0004063584,0.001395886,0.3847297,0.0001374374,0.0005443256,0.1229459],"study_design_scores_gemma":[0.03802341,0.8075672,0.08066356,0.00002369915,0.001492542,0.0006875936,0.0001106248,0.003931272,0.0658835,0.0001196086,0.001424883,0.00007218331],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990902,0.000435757,0.0001835805,0.00001253933,0.00001337536,0.00005680918,0.00003531145,0.00001423495,0.0001581116],"genre_scores_gemma":[0.9978424,0.0003754903,0.001108377,0.0000315938,0.00005114217,0.00008968618,0.0000974729,0.000006678792,0.0003971465],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001404295,"threshold_uncertainty_score":0.004148424,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1195877454496215,"score_gpt":0.4448748509857567,"score_spread":0.3252871055361352,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}